Latest Technology News

HITIQ Limited has received $1.6 million from the R&D Tax Incentive Scheme, using most of it to repay its RDTI Facility with Keystone Capital Partners, signaling a strategic move to streamline its R&D funding.

Immuron has submitted its Phase 2 clinical study report for Travelan® to the FDA, revealing statistically significant immunological and microbiome benefits. The company is preparing to engage the FDA for Phase 3 trial discussions while progressing a large field study with military personnel.

Vonex Limited has vested performance rights for its CEO and directors following MaxoTel’s acquisition of majority control, with shares set to be sold on-market. The company reports a mixed 1H FY25 financial performance and is exploring options to repay a $23 million debt facility, including a potential capital raise.

Mesoblast has raised A$260 million through a global private placement to fund the US commercial launch of its FDA-approved cell therapy Ryoncil® and accelerate clinical development in chronic low back pain.

EQ Resources announces a strategic leadership reshuffle, transitioning CEO Kevin MacNeill to CTO to sharpen operational focus and support ambitious growth plans across Australia and Spain.

Basin Energy advances its Scandinavian uranium exploration with new land applications and awaits key sampling results, buoyed by Sweden's move to lift its uranium mining ban.

McLaren Minerals has successfully raised $1.5 million through a shortfall placement, bolstering its efforts to advance the Pre-Feasibility Study for its McLaren Mineral Sands Project in Western Australia.

Element 25 has obtained key regulatory approval from WA's DEMIRS for its Butcherbird Expansion Project, paving the way for a twelve-year production run at 1.1 million tonnes per annum of manganese concentrate. The final hurdle remains the Works Approval, expected imminently.

Calix Limited has extended its Share Purchase Plan closing date to January 31, 2025, offering eligible shareholders more time to invest up to $30,000 each. The company may close the plan early if subscriptions exceed $5 million, signaling strong investor interest in its decarbonisation technology.

Way2VAT has locked in A$1.3 million through convertible notes aimed at bolstering working capital and accelerating client expansion, pending shareholder approval for conversion.

Chilwa Minerals has reported compelling geochemical results from initial soil sampling at its Lake Chilwa project, revealing significant concentrations of niobium and rare earth elements. These findings bolster the company's dual exploration strategy and set the stage for accelerated drilling campaigns.

Australian Vanadium Limited has secured critical EPA approval for its Gabanintha Vanadium Project, marking a significant step toward construction and production within its broader Australian Vanadium Project.